Glenmede Trust’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-9,965
| Closed | -$256K | – | 1421 |
|
|
2024
Q4 | $256K | Sell |
9,965
-17,455
| -64% | -$449K | ﹤0.01% | 1158 |
|
|
2024
Q3 | $455K | Buy |
27,420
+290
| +1% | +$4.81K | ﹤0.01% | 965 |
|
|
2024
Q2 | $521K | Buy |
27,130
+14,465
| +114% | +$278K | ﹤0.01% | 890 |
|
|
2024
Q1 | $300K | Buy |
+12,665
| New | +$300K | ﹤0.01% | 1063 |
|